Desoximetasone Spray 0.05%, 0.25%; Dose Ranging Study
Completed
Taro Pharmaceuticals USA
Phase 2
2009-11-01
The objectives of this study are to evaluate the efficacy and safety of two dosing regimens
of desoximetasone 0.05% and 0.25% topical sprays as compared to a vehicle spray in patients
with moderate to severe plaque psoriasis.
Desoximetasone Spray 0.25%, Hypothalamic Pituitary Adrenal (HPA) Axis Study
Completed
Taro Pharmaceuticals USA
Phase 2
2010-02-01
The objective of this study is to evaluate the potential of desoximetasone 0.25% topical
spray to suppress HPA axis function. The potential for adrenal suppression will be assessed
following multiple dosing with Desoximetasone 0.25% Topical Spray in patients with moderate
to severe plaque psoriasis. The secondary objectives are to evaluate the efficacy parameters
and to evaluate the adverse event (AE) profile.
Effects of Desoximetasone Spray 0.25% in Patients With Moderate to Severe Plaque Psoriasis
Completed
Taro Pharmaceuticals USA
Phase 3
2010-08-01
The objective of this study is to demonstrate that desoximetasone 0.25% topical spray is
effective for the treatment of patients with moderate to severe plaque psoriasis.
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.
Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data.
The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free.
thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user.
Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
Alerts Available With Subscription
Alerts are available for users with active subscriptions.
